Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

NCT00650936 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT00650936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00650936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2007
Completion date
June 30, 2014
Enrollment
1,000 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

atrial septal defect